Shirkadda Israa'iil ee IceCure Medical ayaa heshay ogolaansho ka timid Maamulka Qaranka ee Alaabada Caafimaadka ee Shiinaha (NMPA) ee nidaamkeeda qaboojinta ee ProSense, taasoo ballaarineysa daawaynta kansarka.
Shirkad Israa'iili ah oo lagu magacaabo IceCure Medical ayaa la saxiixatay Scovas Medical si ay si gaar ah ugu qaybiso daawaynta kansarka ee ProSense cryoablation ee dalka Netherlands.
Tignoolajiyada ProSense ee IceCure Medical ee lagu qaboojiyo burooyinka ayaa helaysa aqoonsi ganacsi oo ka socda Brazil, iyadoo loo adeegsanayo burooyinka naasaha, sambabada, kelyaha iyo kuwa muruqyada lafaha ah.
Daaweynta kansarka naasaha ee IceCure Medical ee ProSense cryoablation, oo ah daaweyn aan qalliin lahayn, ayaa hadda la baarayaa FDA-da iyadoo la sameynayo daraasad la yiraahdo "ChoICE.
